Stereotaxis (STXS) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Stereotaxis (STXS) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 23.94% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -34.15% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 0.98% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -58.26% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.64% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.33% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -188.83% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 38.46% |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | -0.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.57% |
| Dec 31, 2025 | 25.39% |
| Sep 30, 2025 | -4.10% |
| Jun 30, 2025 | 32.71% |
| Mar 31, 2025 | -26.85% |
| Dec 31, 2024 | -45.73% |
| Sep 30, 2024 | -14.21% |
| Jun 30, 2024 | -16.36% |
| Mar 31, 2024 | 14.79% |
| Dec 31, 2023 | -19.75% |
| Sep 30, 2023 | -8.58% |
| Jun 30, 2023 | 3.24% |
| Mar 31, 2023 | -28.55% |
| Dec 31, 2022 | -21.64% |
| Sep 30, 2022 | -6.03% |
| Jun 30, 2022 | -253.75% |
| Mar 31, 2022 | -136.84% |
| Dec 31, 2021 | -142.75% |
| Sep 30, 2021 | -158.71% |
| Jun 30, 2021 | 31.69% |